HALO
Price
$57.15
Change
-$0.48 (-0.83%)
Updated
Jul 11 closing price
Capitalization
7.04B
31 days until earnings call
LGVN
Price
$1.42
Change
-$0.08 (-5.33%)
Updated
Jul 11 closing price
Capitalization
21.31M
Interact to see
Advertisement

HALO vs LGVN

Header iconHALO vs LGVN Comparison
Open Charts HALO vs LGVNBanner chart's image
Halozyme Therapeutics
Price$57.15
Change-$0.48 (-0.83%)
Volume$1.24M
Capitalization7.04B
Longeveron
Price$1.42
Change-$0.08 (-5.33%)
Volume$559.68K
Capitalization21.31M
HALO vs LGVN Comparison Chart in %
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HALO vs. LGVN commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a StrongBuy and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (HALO: $57.15 vs. LGVN: $1.42)
Brand notoriety: HALO and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 41% vs. LGVN: 141%
Market capitalization -- HALO: $7.04B vs. LGVN: $21.31M
HALO [@Biotechnology] is valued at $7.04B. LGVN’s [@Biotechnology] market capitalization is $21.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 3 TA indicator(s) are bullish while LGVN’s TA Score has 7 bullish TA indicator(s).

  • HALO’s TA Score: 3 bullish, 5 bearish.
  • LGVN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than HALO.

Price Growth

HALO (@Biotechnology) experienced а +5.83% price change this week, while LGVN (@Biotechnology) price change was +8.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

HALO is expected to report earnings on Nov 10, 2025.

LGVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.04B) has a higher market cap than LGVN($21.3M). HALO YTD gains are higher at: 19.536 vs. LGVN (-17.919). HALO has higher annual earnings (EBITDA): 705M vs. LGVN (-16.49M). HALO has more cash in the bank: 748M vs. LGVN (14.3M). LGVN has less debt than HALO: LGVN (1.3M) vs HALO (1.51B). HALO has higher revenues than LGVN: HALO (1.08B) vs LGVN (2.23M).
HALOLGVNHALO / LGVN
Capitalization7.04B21.3M33,061%
EBITDA705M-16.49M-4,276%
Gain YTD19.536-17.919-109%
P/E Ratio15.20N/A-
Revenue1.08B2.23M48,719%
Total Cash748M14.3M5,231%
Total Debt1.51B1.3M116,371%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOLGVN
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
68%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBGHX13.77N/A
N/A
Hartford Healthcare HLS IB
LMCRX33.57N/A
N/A
Lord Abbett Mid Cap Stock R3
ETIMX14.70N/A
N/A
Eventide Balanced Fund Class I
CFIHX76.82-0.32
-0.41%
American Funds Capital Income Bldr F3
ARTMX35.33-0.29
-0.81%
Artisan Mid Cap Investor

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-5.33%
QURE - LGVN
36%
Loosely correlated
-3.23%
SNGX - LGVN
35%
Loosely correlated
N/A
SRPT - LGVN
34%
Loosely correlated
-4.69%
PROK - LGVN
34%
Loosely correlated
-12.36%
LGND - LGVN
32%
Poorly correlated
-2.62%
More